Feinstein Institutes Researchers Identify New Molecular Targets to Curb Obesity, Fatty Liver Diseases
To address this issue and help reduce obesity and the development of fatty liver diseases, scientists at The Feinstein Institutes for Medical Research identified new molecular targets that could lead to future treatment.
- To address this issue and help reduce obesity and the development of fatty liver diseases, scientists at The Feinstein Institutes for Medical Research identified new molecular targets that could lead to future treatment.
- View the full release here: https://www.businesswire.com/news/home/20211215006027/en/
Lopa Mishra, MD, co-director of the Institute of Bioelectronic Medicine at the Feinstein Institutes. - (Credit: The Feinstein Institutes)
The research, led by Lopa Mishra, MD , co-director for the Institute of Bioelectronic Medicine at the Feinstein Institutes, was published in Science Translational Medicine . - Dr. Mishras leadership in revealing basic molecular mechanisms of liver disease bridges the gap between her lab and a patients bedside.